C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/13 (2006.01) A61K 39/395 (2006.01) C07K 16/38 (2006.01) C07K 16/46 (2006.01) C12N 5/18 (2006.01) G01N 33/86 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2266341
The present invention relates to a novel alpha-2-antiplasmin-binding molecules and treatment for pulmonary embolism, myocardial infarction, thrombosis or stroke in a patient which comprises administering an alpha-2-antiplasmin- binding molecule capable of preventing inibition of plasmin by endogenous alpha-2-antiplasmin. The invention also relates to a treatment for pulmonary embolism, myocardial infarction, thrombosis or stroke in a patient comprising coadministering an alpha-2-antiplasmin-binding molecule of the invention together with a thrombolytic agent.
Nouvelle molécule capable de liaison avec l'alpha-2-antiplasmine, et traitement pour l'embolie pulmonaire, l'infarctus du myocarde, la thrombose ou l'accident vasculaire cérébral chez un patient, qui consiste à administrer ce nouveau type de molécule capable d'empêcher l'inhibition de la plasmine par alpha-2-antiplasmine andogène. On décrit aussi un traitement pour l'embolie pulmonaire, l'infarctus du myocarde, la thrombose ou l'accident vasculaire cérébral chez un patient, qui consiste à administrer conjointement la molécule en question et un agent thrombolytique.
Mbm Intellectual Property Law Llp
The General Hospital Corporation
The President And Fellows Of Harvard College
LandOfFree
Composition and method for enhancing fibrinolysis using... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and method for enhancing fibrinolysis using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method for enhancing fibrinolysis using... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1564522